Galectin-3 is a biomarker of atrial fibrosis, as its levels determine the degree of fibrosis and atrial remodeling and are associated with early detection of AF patients with a high rate of recurrence after ablation or progression to permanent forms. Here, LGALS3 is linked to atrial fibrillation.